COVID-19 and emerging viral infections: The case for interferon lambda
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19 and emerging viral infections: The case for interferon lambda
Authors
Keywords
-
Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 217, Issue 5, Pages -
Publisher
Rockefeller University Press
Online
2020-04-14
DOI
10.1084/jem.20200653
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus
- (2020) Rishi R. Goel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Interferon Lambda Inhibits Bacterial Uptake During Influenza Super-Infection
- (2019) Helen E. Rich et al. INFECTION AND IMMUNITY
- Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
- (2019) Adriana Forero et al. IMMUNITY
- Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion
- (2019) Achille Broggi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission
- (2018) Jonas Klinkhammer et al. eLife
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness
- (2017) Ioanna E. Galani et al. IMMUNITY
- IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment
- (2016) Sophia Davidson et al. EMBO Molecular Medicine
- Lambda Interferon Restructures the Nasal Microbiome and Increases Susceptibility to Staphylococcus aureus Superinfection
- (2016) Paul J. Planet et al. mBio
- IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production
- (2015) Katrina Blazek et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Disease-Promoting Effects of Type I Interferons in Viral, Bacterial, and Coinfections
- (2015) Sophia Davidson et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection
- (2014) Andrew J. Muir et al. JOURNAL OF HEPATOLOGY
- A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
- (2013) Ludmila Prokunina-Olsson et al. NATURE GENETICS
- Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia
- (2013) Stefania Crotta et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started